G1 Therapeutics to Present at 35th Annual J.P. Mor
Post# of 301275
RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. , a clinical-stage oncology company, announced today that Chief Executive Officer Mark Velleca, MD, PhD, will present a company overview at the 35th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, January 10, at 9 a.m. PT at The Westin St. Francis Hotel in San Francisco.
About G1 Therapeutics, Inc.
G1 Therapeutics is a clinical-stage oncology company developing novel, small-molecule therapies that address significant unmet needs in people with cancer. The company is advancing a pipeline of potential best-in-class and first-in-class drug candidates in multiple oncology indications. G1 is privately held and based in Research Triangle Park, NC.
Visit www.g1therapeutics.com for more information.
Contact: Mark Velleca, MD, PhD G1 Therapeutics 919-213-9838 mvelleca@g1therapeutics.com Investors: Robert Uhl Westwicke Partners 858-356-5932 robert.uhl@westwicke.com Media: Laura Bagby 6 Degrees Communications 312-448-8098 lbagby@6degreespr.com
(0)
(0)